<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03999060</url>
  </required_header>
  <id_info>
    <org_study_id>TrigeminalBrainstemMapping</org_study_id>
    <nct_id>NCT03999060</nct_id>
  </id_info>
  <brief_title>Trigeminal Brainstem Mapping</brief_title>
  <official_title>Brainstem Mapping of Nociceptive Trigeminal Input</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To what extent the somatotopy of the 3 branches of the trigeminal nerve (V1,V2,V3) as well as
      the greater occipital nerve (GON) in the brainstem but also in the thalamus and the insula
      can be mapped using functional imaging and BOLD in humans is not known but might play an
      important role in imaging headache diseases. The aim is to map their somatotopy by random
      stimulation of V1, V2, V3 and the GON with painful electrical input during acquisition of
      BOLD-fMRI.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 28, 2019</start_date>
  <completion_date type="Actual">September 27, 2019</completion_date>
  <primary_completion_date type="Actual">September 27, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Statistical Parametric Map calculated from the fMRI data on brainstem level</measure>
    <time_frame>through study completion, an average of 9 months</time_frame>
    <description>At a statistical threshold of T-value 3 we will observe a somatotopical arrangement in the brainstem below the pons:
Expected location for V1: within radius of 10 mm around the MNI coordinates (-1,-48,-75); Expected location for V2: within radius of 10 mm around the MNI coordinates (-4,-47,-69) Expected location for V3: within radius of 10 mm around the MNI coordinates (-1,-46,-66) Expected location for GON: within radius of 10 mm around the MNI coordinates (-1,-45,-64)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Statistical Parametric Map calculated from the fMRI data in the thalamus</measure>
    <time_frame>through study completion, an average of 9 months</time_frame>
    <description>At a statistical threshold of T-value 4 we will observe a somatotopical arrangement in the thalamus:
Expected location for V1: within radius of 10 mm around the MNI coordinates (11,-5,6); Expected location for V2: within radius of 10 mm around the MNI coordinates (13,-11,5) Expected location for V3: within radius of 10 mm around the MNI coordinates (12,-10,5) Expected location for GON: within radius of 10 mm around the MNI coordinates (15,-12,-7)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Statistical Parametric Map calculated from the fMRI data in the insula</measure>
    <time_frame>through study completion, an average of 9 months</time_frame>
    <description>At a statistical threshold of T-value 4 we will observe a somatotopical arrangement in the insula:
Expected location for V1: within radius of 10 mm around the MNI coordinates (38,-15,8); Expected location for V2: within radius of 10 mm around the MNI coordinates (37,-8,-5) Expected location for V3: within radius of 10 mm around the MNI coordinates (39,2,-11) Expected location for GON: within radius of 10 mm around the MNI coordinates (38,-12,-3)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Statistical Parametric Map calculated from the fMRI data in the cerebellum</measure>
    <time_frame>through study completion, an average of 9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Statistical Parametric Map calculated from the fMRI data in the periaqueductal gray (PAG)</measure>
    <time_frame>through study completion, an average of 9 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Headache Disorders, Primary</condition>
  <condition>Migraine</condition>
  <arm_group>
    <arm_group_label>Electric Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electric Current Stimulation</intervention_name>
    <description>Electric stimulation with a Digitimer DS7AH HV Current Stimulator delivered with 4 shielded electrodes mounted on the participants head</description>
    <arm_group_label>Electric Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy

          -  suitable fo MRI

        Exclusion Criteria:

          -  headache disease

          -  psychological disorder

          -  pregnancy

          -  all exclusion criteria necessary for imaging in a 3 T MRI scanner
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arne May, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Hamburg-Eppendorf</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UKE</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>June 13, 2019</study_first_submitted>
  <study_first_submitted_qc>June 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 26, 2019</study_first_posted>
  <last_update_submitted>October 6, 2019</last_update_submitted>
  <last_update_submitted_qc>October 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Headache Disorders</mesh_term>
    <mesh_term>Headache Disorders, Primary</mesh_term>
    <mesh_term>Headache</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Group results will be presented at international conferences as well as published in international peer-reviewed journals</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

